Nick Train anticipates period of poor performance for his trust
No surprise if such a highly concentrated portfolio hits the skids ‘at some point’
No surprise if such a highly concentrated portfolio hits the skids ‘at some point’
|
|
Woodford protege has been in the spotlight as his former mentor comes under fire
|
|
Emerging markets trust currently trades at a 6.2% discount
|
|
Global equities investment trust uses bond benchmark to calculate performance fee
|
|
‘They’ve stopped short of an unequivocal statement of confidence in the manager’
|
|
Three quarters of Patient Capital holdings also sit in gated Equity Income fund
|
|
But are they setting up investors for a fall?
|
|
Star manager buys stock as discount on emerging markets trust widens
|
|
Michael O’Brien and Sandip Patodia to take over as fees are slashed
|
|
Hargreaves Lansdown delivered 21% for his investment trust in April
|
|
£7bn investment trust now holds 17.3% in unlisted companies
|
|
Big consumer brand stocks have not become ‘perilously expensive’
|
|